A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality
- 12 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 20 (5) , 827-836
Abstract
The European Heart SCORE model constitutes the basis for national guidelines for primary prevention and treatment of cardiovascular disease (CVD) in several European countries. The model estimates individuals’ 10-year CVD mortality risks from age, sex, smoking status, systolic blood pressure, and total cholesterol level. The SCORE model, however, is not mathematically consistent and does not estimate all-cause mortality. Our aim is to modify the SCORE model to allow consistent estimation of both CVD-specific and all-cause mortality. Using a competing risk approach, we first re-estimated the cause-specific risk of dying from cardiovascular disease, and secondly we incorporated non-CVD mortality. Finally, non-CVD mortality was allowed to also depend on smoking status, and not only age and sex. From the models, we estimated CVD-specific and all-cause 10-year mortality risk, and the expected residual lifetime together with corresponding expected effects of statin treatment. The modified model provided CVD-specific 10-year mortality risks similar to those of the European Heart SCORE model. Incorporation of non-CVD mortality increased 10-year mortality risks, in particular for older individuals. When non-CVD mortality was assumed unaffected by smoking status, the absolute risk reduction due to statin treatment ranged from 0.0% to 3.5%, whereas the gain in expected residual lifetime ranged from 3 to 11 months. Statin effectiveness increased for non-smokers and declined for smokers, when smoking was allowed to influence non-CVD mortality. The modified model provides mathematically consistent estimates of mortality risk and expected residual lifetime together with expected benefits from statin treatment.Keywords
This publication has 15 references indexed in Scilit:
- Evaluation of cardiovascular risk predicted by different SCORE equations: The Netherlands as an exampleEuropean Journal of Preventive Cardiology, 2010
- Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chartEuropean Journal of Preventive Cardiology, 2009
- Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation GermanyEuropean Journal of Preventive Cardiology, 2008
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)European Heart Journal, 2007
- Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population surveyBMC Medical Informatics and Decision Making, 2007
- The SCORE risk model applied to recent population surveys in Norway compared to observed mortality in the general populationEuropean Journal of Preventive Cardiology, 2006
- The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortalityEuropean Journal of Preventive Cardiology, 2005
- A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: Number needed to treat versus postponement of hip fractureClinical Therapeutics, 2003
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal, 2003
- The Statistical Analysis of Failure Time Data2002